Aragen - About the company
Aragen is a series B company based in Hyderabad (India), founded in 2001 by Kamal Kumar P. It operates as a Provider of drug discovery, clinical development, manufacturing, and other services for small molecules. Aragen has raised $161M in funding from investors like Quadria Capital, Sequoia Capital and Goldman Sachs, with a current valuation of $*****. The company has 323 active competitors, including 21 funded and 98 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and KBI Biopharma.
Company Details
- Website
- www.aragen.com/
- Email ID
- *****@aragen.com
- Phone Number
- +91 **********
- Registered Address
- Morgan Hill, California
Key Metrics
Founded Year
2001
Location
Hyderabad, India
Stage
Series B
Total Funding
$161M in 4 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jan 08, 2025
Investors
Ranked
3rd among 323 active competitors
Annual Revenue
₹1,000+ Cr as on Mar 31, 2025
Employee Count
4,272 as on May 31, 2025
Similar Companies
Legal entities associated with Aragen
Aragen is associated with 5 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
GVK DAVIX TECHNOLOGIES PRIVATE LIMITED CIN: U74110TG2005PTC045481 , India, Amalgamated | Feb 25, 2005 | ₹1,000+ Cr (As on Mar 31, 2021) | - | |
ARAGEN BIOSCIENCE, INC. CIN: 810655676 , United States, Active | Dec 31, 1999 | - | 67 (As on Dec 31, 2024) | - |
ARAGEN LIFE SCIENCES LIMITED CIN: U74999TG2000PLC035826 , India, Active | Dec 07, 2000 | ₹1,000+ Cr (As on Mar 31, 2025) | 4067 (As on Apr 01, 2026) | |
EXCELRA KNOWLEDGE SOLUTIONS PRIVATE LIMITED CIN: U72100TG2006PTC049287 , India, Active | Feb 24, 2006 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 574 (As on Mar 01, 2026) | |
INOGENT LABORATORIES PRIVATE LIMITED CIN: U24239TG2005PTC046402 , India, Amalgamated | Jun 01, 2005 | ₹100 - ₹500 Cr (As on Mar 31, 2017) | - |
Sign up to download Aragen's company profile
Aragen's funding and investors
Aragen has raised a total funding of $161M over 4 rounds. Its first funding round was on Nov 08, 2007. Its latest funding round was a PE round on Aug 13, 2025 for $*****. 1 investor participated in its latest round. Aragen has 15 institutional investors and 5 angel investors.
Here is the list of recent funding rounds of Aragen:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 13, 2025 | 7853194 | PE | 5862471 | 9166208 | 2177639 | 7528828 |
Jan 08, 2025 | 3116551 | PE | 5638395 | 7564882 | 8020348 | 8151306 |
May 24, 2021 | 6806794 | Series B | 3544471 | 2370673 | 1042873 |
View details of Aragen's funding rounds and investors
Aragen's founders and board of directors
Founder? Claim ProfileThe founders of Aragen is Kamal Kumar P. Aniel Khubchandani and Manni Kantipudi are the CEOs of Aragen.
Here are the details of Aragen's key team members:
- Kamal Kumar P: Deputy General Manager of Aragen. Contact Info: 1 email address and 1 phone number
- Manni Kantipudi: CEO of Aragen. They serve on the board of 1 company.Contact Info: 1 email address and 1 phone number
Aragen's Board of Directors
Aragen's board has 14 active members. Davinder Singh Brar, Rajat Sood, Amit Varma, GV Sanjay Reddy and Manni Kantipudi are part of team and Adam Dawson, Ajay Srivastava, Ajay Srivastava, Gunapati Reddy Venkat Keshav, Manmahesh Kantipudi, Anita Ramachandran, Gerhard Mayr, Robert Ruffolo and Sahajbir Singh Brar are independent board members.Here is the list of Aragen's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 25y 7m | |
jfgkwrk | Team | - | Current | 2y 8m |
nzafayw | Team | - | Current | 5y 9m |
Investor | - | Current | 1y 6m | |
zdvkrfm | Investor | - | Past | 2y 5m |
Independent board member | - | Current | 5y 0m | |
kfxthmp | Independent board member | - | Current | 3y 1m |
viilsdv | Independent board member | - | Current | 2y 8m |
bxqgerb | Independent board member | - | Current | 7y 6m |
cbjgiln | Independent board member | - | Past | 7y 6m |
dzwjurp | Independent board member | - | Past | 1y 6m |
jbmuivw | Independent board member | - | Past | 5y 1m |
tpkxkmm | Independent board member | - | Past | 3y 2m |
ietenhq | Independent board member | - | Past | 3y 9m |
sqzqwut | Independent board member | - | Past | 4y 7m |
rqrrkpm | Independent board member | - | Past | 4y 2m |
kbfnrfq | Independent board member | - | Past | 5y 1m |
ndgyqts | Independent board member | - | Past | 9y 3m |
View details of Aragen's Founder profiles and Board Members
Aragen's employee count trend
Aragen has 4,272 employees as of May 25. The total employee count is 11.0% more than what it was in May 24. Here is Aragen's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Aragen's Competitors and alternates
Top competitors of Aragen include Anthem Biosciences, Patheon and KBI Biopharma. Here is the list of Top 10 competitors of Aragen, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Anthem Biosciences 2006, Bengaluru (India), Public | Developer of integrated contract research development and manufacturing services | $35.7M | 77/100 | |
2nd | Patheon 1974, Durham (United States), Acquired | Global CDMO providing integrated drug development, clinical trials, and manufacturing services | $141M | 75/100 | |
3rd | Provider of drug discovery, clinical development, manufacturing, and other services for small molecules | $161M | 69/100 | ||
4th | KBI Biopharma 1996, Durham (United States), Acquired | Provider of protein formulation, process & cell line development, and cGMP services | $21M | 68/100 | |
5th | Provider of contract research and manufacturing services for both small molecules and biologics | $85.9M | 66/100 | ||
6th | Abzena 2001, Cambridge (United Kingdom), Acquired | Provider of antibody discovery, cell line development, and bio analytics services | $67.1M | 66/100 | |
7th | Abingdon Health 2008, York (United Kingdom), Public | Developer of immunoassays for diagnostic purposes | $24.1M | 64/100 | |
8th | Panacea Biotec 1984, Ambala (India), Public | Developer of biosimilars, vaccines and natural products | - | 62/100 | |
9th | Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired | Aseptic manufacturing CDMO providing fill-finish services for sterile injectables | $16.9M | 59/100 | |
10th | Contract development and manufacturing organization for biologics | - | 58/100 |
Looking for more details on Aragen's competitors? Click here to see the top ones
Aragen's Investments and acquisitions
Aragen has made 2 investments in companies including Docplexus and Docplexus. Aragen has also acquired 3 companies including INTOX lab and Vanta Bioscience.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Dec 15, 2021 | Acquisition | 1995 | Pune (India) | |
Aug 01, 2016 | Investments | 2013 | Pune (India) | |
Aug 03, 2015 | Investments | 2013 | Pune (India) |
See all acquisitions by Aragen
Reports related to Aragen
Here is the latest report on Aragen's sector:
News related to Aragen
Media has covered Aragen for a total of 5 events in the last 1 year, 3 of them have been about company updates.
•
•
Aragen to Manufacture Renaissance Pharma’s FDA Fast Track mAbPharmaTimes•Jun 02, 2026•Renaissance Pharmaceutical, Aragen
•
•
Aragen launches ChemiSHE, India’s first women-led chemistry synthesis laboratoryExpress Pharma•Apr 14, 2026•Aragen
•
India’s pharma and healthcare funding declines in August 2025Express Pharma•Sep 03, 2025•Aragen, Eyestem, Aethermt, QRL Bioscience and 2 others
•
Avendus invests $34.2m in Indian pharma services firm AragenTech in Asia•Aug 13, 2025•Aragen, Avendus, SBI Life Insurance
•
Aragen appoints Aniel Khubchandani as CEO of development and manufacturing solutions businessExpress Pharma•Aug 07, 2025•Aragen
•
Aragen Makes New Appointments for Advancing Scientific InnovationsBioSpectrum India•Mar 10, 2025•Aragen
•
Pharma funding surges 191% in January 2025 to $300 millionExpress Pharma•Feb 07, 2025•Neuberg Diagnostics, Aragen, Foxtale
•
Indian startups raise $1.76 Bn in JanuaryEntrackr•Feb 03, 2025•Impetus Technologies, Innovaccer, Infra.Market, Aragen and 34 others
Are you a Founder ?
FAQs about Aragen
Explore our recently published companies
- Specifictoolsng - 2007 founded, Unfunded company
- Dgn-Kilters - Unfunded company
- Ludlowfitness - 2006 founded, Unfunded company
- Syracuseindoorsportscenter - Unfunded company
- Ultimateperformance - Unfunded company
- Calstreethockey - 1999 founded, Unfunded company
